Advanced Search
Contact | Corporate | Help

Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type

Sponsors:
  • Assistance Publique - Hôpitaux de Paris
  • Aventis Pharmaceuticals
Phases:
  • Phase III
IndicationsAcronym:
  • Ehlers-Danlos Syndrome, Type Iv, Autosomal Dominant
  • Gene Map Locus 2q31
Age Groups:
  • Child
  • Adult
Gender:
Both
Names:
  • Drug: celiprolol
Enrollment:
100

Additional information about NCT00190411.


SourceSolution © 2008-2012